ENDRA Life Sciences Inc. — Director's Dealing 2019

Dec 11, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2019-12-11

Reporting Person: Tokman Alexander Y (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-11	Stock option (right to buy)	$0.90	A	89585	Acquired	2029-12-11	Common Stock (89585)	Direct

Footnotes

F1: These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date.